Michael Brian Bell's most recent trade in Guardant Health Inc was a trade of 3,914 Common Stock done at an average price of $170.8 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.77 per share. | 01 Jul 2026 | 3,914 | 51,816 (0%) | 0% | 170.8 | 668,394 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 3,324 | 16,620 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 3,324 | 53,860 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 2,084 | 2,085 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 2,084 | 50,536 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,870 | 13,093 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 1,870 | 55,730 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 2,039 | 49,548 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2026 | 2,039 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 129.82 per share. | 15 Jun 2026 | 1,096 | 48,452 (0%) | 0% | 129.8 | 142,283 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 128.62 per share. | 05 Jun 2026 | 2,000 | 47,509 (0%) | 0% | 128.6 | 257,241 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 7,369 | 14,963 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 7,369 | 56,378 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.15 per share. | 01 Apr 2026 | 6,869 | 49,509 (0%) | 0% | 91.1 | 626,109 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 3,324 | 19,944 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 3,324 | 49,009 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 2,084 | 45,685 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 2,084 | 4,169 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,518 | 51,975 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 10,518 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.49 per share. | 15 Mar 2026 | 7,413 | 46,601 (0%) | 0% | 85.5 | 633,737 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.04 per share. | 15 Mar 2026 | 3,000 | 43,601 (0%) | 0% | 87.0 | 261,111 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 2,039 | 54,014 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 2,039 | 2,039 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 1,233 | 41,457 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 1,233 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 26,582 | 26,582 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.14 per share. | 01 Jan 2026 | 12,479 | 40,224 (0%) | 0% | 102.1 | 1,274,605 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 10,520 | 40,185 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 10,520 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 7,110 | 50,619 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 7,110 | 7,110 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 3,324 | 43,509 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 3,324 | 23,268 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,084 | 52,703 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,084 | 6,253 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 2,039 | 4,078 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 2,039 | 31,324 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.67 per share. | 15 Dec 2025 | 1,659 | 29,665 (0%) | 0% | 102.7 | 170,330 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,233 | 1,233 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,233 | 29,285 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.86 per share. | 05 Dec 2025 | 29,382 | 81,509 (0%) | 0% | 32.9 | 965,493 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 29,382 | 7,137 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.37 per share. | 05 Dec 2025 | 26,905 | 108,414 (0%) | 0% | 28.4 | 763,295 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2025 | 26,905 | 10,421 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.11 per share. | 05 Dec 2025 | 22,891 | 77,490 (0%) | 0% | 102.1 | 2,337,302 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.96 per share. | 05 Dec 2025 | 11,978 | 57,945 (0%) | 0% | 104.0 | 1,245,252 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.11 per share. | 05 Dec 2025 | 8,774 | 40,086 (0%) | 0% | 102.1 | 895,932 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.42 per share. | 05 Dec 2025 | 8,033 | 100,381 (0%) | 0% | 101.4 | 814,736 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.26 per share. | 05 Dec 2025 | 7,567 | 69,923 (0%) | 0% | 103.3 | 781,394 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 106.68 per share. | 05 Dec 2025 | 5,568 | 52,127 (0%) | 0% | 106.7 | 594,018 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.96 per share. | 05 Dec 2025 | 5,027 | 32,526 (0%) | 0% | 104.0 | 522,611 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 106.70 per share. | 05 Dec 2025 | 3,284 | 29,242 (0%) | 0% | 106.7 | 350,408 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.46 per share. | 05 Dec 2025 | 3,267 | 48,860 (0%) | 0% | 101.5 | 331,483 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.24 per share. | 05 Dec 2025 | 2,533 | 37,553 (0%) | 0% | 103.2 | 261,509 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 107.26 per share. | 05 Dec 2025 | 1,190 | 28,052 (0%) | 0% | 107.3 | 127,642 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 105.82 per share. | 05 Dec 2025 | 250 | 57,695 (0%) | 0% | 105.8 | 26,454 | Common Stock |
| Guardant Health Inc | Brian Michael Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 13,097 | 26,592 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Brian Michael Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 13,097 | 59,822 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Bell Michael Brian | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.65 per share. | 01 Oct 2025 | 7,695 | 52,127 (0%) | 0% | 62.7 | 482,092 | Common Stock |
| Guardant Health Inc | Brian Bell Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 2,084 | 46,725 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Brian Bell Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 2,084 | 8,337 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 2,039 | 46,300 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 2,039 | 6,117 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.79 per share. | 15 Sep 2025 | 1,659 | 44,641 (0%) | 0% | 54.8 | 90,897 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 1,233 | 2,466 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2025 | 1,233 | 44,261 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 2,084 | 44,085 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 2,084 | 10,421 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.71 per share. | 01 Jul 2025 | 1,057 | 43,028 (0%) | 0% | 50.7 | 53,600 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 2,039 | 8,156 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 2,039 | 43,660 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.29 per share. | 15 Jun 2025 | 1,659 | 42,001 (0%) | 0% | 49.3 | 81,772 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,233 | 41,621 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,233 | 3,699 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,084 | 12,505 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 2,084 | 41,445 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 01 Apr 2025 | 1,057 | 40,388 (0%) | 0% | 42.5 | 44,891 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,039 | 10,195 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,039 | 41,020 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.89 per share. | 15 Mar 2025 | 1,659 | 39,361 (0%) | 0% | 42.9 | 71,155 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,233 | 38,981 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,233 | 4,932 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 33,498 | 33,498 | - | - | Stock Option (Right to Buy) | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 22,332 | 22,332 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 7,108 | 14,220 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 7,108 | 40,285 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.55 per share. | 01 Mar 2025 | 2,537 | 37,748 (0%) | 0% | 42.5 | 107,949 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 6,617 | 35,538 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 6,617 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.98 per share. | 01 Feb 2025 | 2,361 | 33,177 (0%) | 0% | 47.0 | 110,920 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,309 | 30,226 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,309 | 0 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.50 per share. | 15 Jan 2025 | 1,305 | 28,921 (0%) | 0% | 37.5 | 48,938 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 2,084 | 27,772 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 2,084 | 14,589 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.55 per share. | 01 Jan 2025 | 855 | 26,917 (0%) | 0% | 30.5 | 26,120 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 2,039 | 12,234 | - | - | Restricted Stock Units | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 2,039 | 27,347 (0%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 15 Dec 2024 | 1,659 | 25,688 (0%) | 0% | 34.8 | 57,667 | Common Stock |
| Guardant Health Inc | Michael Brian Bell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 1,233 | 25,308 (0%) | 0% | 0 | Common Stock |